Massive jury award against J & J highlights risks of its legal strategy

A jury award that hit Johnson& Johnson with $8 billion in punitive damages for a case involving its anti-psychotic drug Risperdal highlights the risks of the drugmaker's all-or-nothing legal strategy, several legal experts told Reuters on Wednesday.

Source: Reuters: Health - October 9, 2019 Category: Consumer Health News Tags: healthNews Source Type: news